These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32765584)

  • 41. Clinical significance of CD38 and CD101 expression in PD-1
    Zhou J; Wang W; Liang Z; Ni B; He W; Wang D
    Oncol Lett; 2020 Jul; 20(1):724-732. PubMed ID: 32565998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
    Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
    J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation.
    Chernaya G; Mikhno N; Khabalova T; Svyatchenko S; Mostovich L; Shevchenko S; Gulyaeva L
    Surg Oncol; 2018 Dec; 27(4):702-708. PubMed ID: 30449496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overview of CD24 as a new molecular marker in ovarian cancer.
    Tarhriz V; Bandehpour M; Dastmalchi S; Ouladsahebmadarek E; Zarredar H; Eyvazi S
    J Cell Physiol; 2019 Mar; 234(3):2134-2142. PubMed ID: 30317611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.
    Kurokawa A; Nagata M; Kitamura N; Noman AA; Ohnishi M; Ohyama T; Kobayashi T; Shingaki S; Takagi R;
    Cancer; 2008 Mar; 112(6):1272-81. PubMed ID: 18224668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of association between markers in the ITGA3, ITGAV, ITGA6 and ITGB3 and autism in an Irish sample.
    Cochrane LE; Tansey KE; Gill M; Gallagher L; Anney RJ
    Autism Res; 2010 Dec; 3(6):342-4. PubMed ID: 21182210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells.
    Zhang H; Cui X; Cao A; Li X; Li L
    Gene; 2020 Apr; 734():144396. PubMed ID: 31987909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of tumor PD-L1 expression combined with CD8
    Wang Q; Lou W; Di W; Wu X
    Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
    Zhang H; Lu J; Yang Y; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
    Yang M; Xie X; Ding Y
    Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.
    Li R; Zhuang C; Jiang S; Du N; Zhao W; Tu L; Cao H; Zhang Z; Chen X
    J Cancer; 2017; 8(18):3764-3773. PubMed ID: 29151964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of integrin α-6 is associated with multi drug resistance and prognosis in ovarian cancer.
    Wei L; Yin F; Chen C; Li L
    Oncol Lett; 2019 Apr; 17(4):3974-3980. PubMed ID: 30930993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic values of transketolase family genes in ovarian cancer.
    Zhao M; Ye M; Zhou J; Zhu X
    Oncol Lett; 2019 Nov; 18(5):4845-4857. PubMed ID: 31611995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
    Huo Q; Li Z; Cheng L; Yang F; Xie N
    Front Oncol; 2020; 10():621. PubMed ID: 32528869
    [No Abstract]   [Full Text] [Related]  

  • 58. Altered integrin expression patterns shown by microarray in human cutaneous melanoma.
    Vizkeleti L; Kiss T; Koroknai V; Ecsedi S; Papp O; Szasz I; Adany R; Balazs M
    Melanoma Res; 2017 Jun; 27(3):180-188. PubMed ID: 28234767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance.
    Zhang J; Yuan B; Zhang H; Li H
    Oncol Lett; 2019 Jun; 17(6):5351-5360. PubMed ID: 31186752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
    Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
    Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.